What are the biggest obstacles to securing financing? What challenges do you face when seeking to establish partnerships, deals, and agreements? What represents the greatest hurdle to the advance of new technologies in healthcare? What are your main concerns when running a clinical trial? How difficult do you find it to attract and retain talent?
Take part in the LSX C-Suite Challenges in Life Sciences Survey 2018 to share your views on the barriers life science executives encounter across financing and IPOs, M&A and deal making, R&D through to commercialisation, IP, regulation and compliance, as well as talent and executive strategy.
Raise awareness of the obstacles that stand in the way of your company’s path to achieving its financial, commercial, and strategic goals, and highlight the issues that need to be addressed to support the life sciences sector’s ongoing development.
The survey is open to responses from the global life sciences C-suite, including senior executives across biotech, medtech, medical devices, diagnostics, and health tech. Whether you are a CEO of a UK-based digital health start-up, a CFO at a growing German medtech company or a CSO of a US listed biotech, we want to hear from you.
The results of the survey will be published in September 2018, enabling life science executives to benchmark their experiences and strategies against those of peers. The report will include industry analysis and insights from leading experts in their fields, all designed to help companies overcome the obstacles they face.
The survey takes no more than 10 minutes to complete. All results will be anonymised.
If you would like to receive a copy of the report upon publication, please leave your name and email address at the end of the survey. As a thank you for taking part, all those who leave their details will be entered into a prize draw to win £50-worth of retail vouchers and a £50 donation to a charity of their choice.
Feature image © monsitj – stock.adobe.com